1. Home
  2. NEWS
  3. Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.

Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.

Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.
State of Science at Porosome Therapeutics, Inc.
Porosome reconstitution therapy: A biologic rescue from cystic fibrosis (In human lung organoids and in CF mice)
Porosome Therapeutics Inc, is proud to announce that Company Chairman Prof. Bhanu P. Jena delivered the Commencement Keynote Address to the 2024 Graduating Medical Class at Wayne State University on 6th June, 2024.